Toujeo is basal, long lasting insulin. Afrezza is Prandial, ultra fast acting insulin for meals....you complete imbeciles. SNY excited and selling both. Get a bloody life, liars.
I've got both. No need to bash here like a dolt.
AMBS has been under a dime for a couple years, with no significant upside movement - and yet idiot pumpers keep invading other boards trying to make it go up a penny or two. You're ill....stay on AMBS board.
I hope he ends up as the bunkmate of a very large, very hairy, very violent tempered, extremely gay viking.
No you aren't. You don't have any money. Just a boilerroom piece of garbage. Ignored.
There aren't even "millions" of shares available. Have you even looked at the share count and float?
I'm looking at their cash position, and their float, and wondering why they wouldn't go ahead and put some more shares out there to brace their cash position, and if it might be prudent to wait and see - but SO TEMPTING to buy into this lift and the fantastic news.....I usually have no problem pulling the trigger, but I'm really torn on this one. Long time investor in Al Mann companies, and I think this is a winner, particularly if they DON'T iussue more shares....but if I were them, with that little cash.....ugh....conundrum.
I'm all over that one, for about 2 weeks - it's been a nice ride so far, and with that low float, the sky is the limit upon approval. Just wish I had bought more in the $6 range.
Nah, not really. Too much buildup when there really shouldn't be any major anything announced today. Where do these silly ideas come from? We've waited this long, and I hate to tell ya, but we're going to wait a while longer - maybe another 6 months. It's frustrating for everyone that believes, but I just don't see any dam breaking news happening today. Just another quarter with no real revenues to speak of - maybe some cool scrips info, that'd be good - but unless there's been some firestorm of scrips in the past week, I really expect the shorts to be able to keep up their lying, stupid games. I hate it as much as you do, believe me....but I also have some freed up cash from another trade, and if we get hit due to no news, I'm ready to make my position an even 10K shares. I'm at 9K now.
With a PE of 75, a market cap of $1.5B, $150M or so in sales last full year - what will earnings have to be to move the needle, and how much growth beyond what's priced in to the stock price is reasonable?
I'm just trying to figure out whether this is a buying opportunity for real. I'm seeing the cam sales as a major growth area, taser sales, etc flat to slight growth....just asking - not bashing, not looking for a bunch of garbage attacks. I just started looking at this one, and trying to figure if it's a bonified trade around earnings.
I like TASR a LOT, but in watch mode now - still debating with myself on that one. Their PE seems to be a bit out of whack, they are at or near 52 week high, but, that said, t they have a reasonable market cap and float, and based on sales announcements, it could run on earnings...Thanks for the internal battle over pulling the trigger...:)
LPCN - oral testosterone with stellar Phase III results, comparable to testosterone injections. On a tear lately, but I think a LOT more upside come approval because of low float and, well, it's a drug for wealthy white guys like me! :)
Oh, no question about that - win or lose, this is the most drama I've been involved in since the great DNDN battle of 2007! I made a crapload then, and I'll make a crapload now...I love battle stocks! Particularly when logic is the linchpin. DNDN lost in the long run, but the science was solid, and sytill is. MNKD not only won on the science, but the sales machine is unstoppable, and now with a HUGE inhale-able insulin nCEO on board....can't lose. This missing link with DNDN was the partnership/sales channel. MNKD is my next 1K% winner, no question, no doubt. (By the way, I made mutiple 500-1K% wins day trading that one.).